Gene expression profiles of PDX models with acquired resistance to endocrine treatments
Ontology highlight
ABSTRACT: Acquired resistance to endocrine therapy occurs with high frequency in patients with luminal breast cancer (LBC). We report here the establishment of four patient-derived xenograft models of LBC with acquired resistance in vivo to tamoxifen and estrogen deprivation. CEL files represent expresison data generated from 5 replicates (independent mice) of the following tumor models: HBCx22 (parental), HBCx22 TamR (tamoxifen-resistant), HBCx22 OvaR (ovariectomy-resistant), HBCx34 (parental), HBCx34 TamR (tamoxifen-resistant), HBCx34 OvaR (ovariectomy-resistant)
ORGANISM(S): Homo sapiens
SUBMITTER: Pierre de la Grange
PROVIDER: E-GEOD-55561 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA